title: Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
abstract: Display of peptides or proteins in an ordered, repetitive array, such as on the surface of a virus-like particle, is known to induce an enhanced immune response relative to vaccination with the "free" protein antigen. The coat protein of Tobacco mosaic virus (TMV) can accommodate short peptide insertions into the primary sequence, but the display of larger protein moieties as genetic fusions to the capsid protein has not been possible. We employed a randomized library approach to introduce a reactive lysine at the externally located amino terminus of the coat protein, which facilitated biotinylation of the capsid. To characterize display of heterologous proteins on the virion surface, we bound a model antigen (green fluorescent protein (GFP)-streptavidin (SA), expressed and purified from plants) to the biotinylated TMV particles, creating a GFP-SA decorated virus particle. A GFP-SA tetramer loading of 26% was obtained, corresponding to approximately 2200 GFP moieties displayed per intact virion. We evaluated the immunogenicity of GFP decorated virions in both mice and guinea pigs and found augmented humoral IgG titers in both species, relative to unbound GFP-SA tetramer. Next, we fused an N-terminal fragment of the Canine oral papillomavirus L2 protein to streptavidin. With TMV display, the L2 protein fragment was significantly more immunogenic than uncoupled antigen when tested in mice. By demonstrating the presentation of whole proteins, this study expands the utility of TMV as a vaccine scaffold beyond that which is possible by genetic manipulation.
authors.affiliation: Large Scale Biology Corporation, Vacaville, CA 95688, USA.
authors.forename: Mark L
authors.initials: ML
authors.lastname: Smith
authors.forename: John A
authors.initials: JA
authors.lastname: Lindbo
authors.forename: Stephan
authors.initials: S
authors.lastname: Dillard-Telm
authors.forename: Paul M
authors.initials: PM
authors.lastname: Brosio
authors.forename: Amanda B
authors.initials: AB
authors.lastname: Lasnik
authors.forename: Alison A
authors.initials: AA
authors.lastname: McCormick
authors.forename: Long V
authors.initials: LV
authors.lastname: Nguyen
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Palmer
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology; D001483:Base Sequence; D004279:DNA, Viral / Q000235:genetics; D004285:Dogs; D005260:Female; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000276:immunology; D006168:Guinea Pigs; D007074:Immunoglobulin G / Q000096:biosynthesis; D051379:Mice; D008807:Mice, Inbred BALB C; D008854:Microscopy, Electron; D027383:Papillomaviridae / Q000235:genetics / Q000276:immunology; D019151:Peptide Library; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D019809:Streptavidin / Q000235:genetics / Q000276:immunology; D014026:Nicotiana / Q000821:virology; D014027:Tobacco Mosaic Virus / Q000235:genetics* / Q000276:immunology* / Q000648:ultrastructure; D014614:Vaccines, Synthetic / Q000235:genetics* / Q000276:immunology*; D015678:Viral Structural Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D004279:DNA, Viral; D007074:Immunoglobulin G; D019151:Peptide Library; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D015678:Viral Structural Proteins; D014765:Viral Vaccines; D049452:Green Fluorescent Proteins; D019809:Streptavidin